πŸ‡ΊπŸ‡Έ FDA
Patent

US 7172869

Methods for transfecting T cells

granted A61KA61K48/00

Quick answer

US patent 7172869 (Methods for transfecting T cells) held by United States of America as represented by the Secretary of the Air Force expires Mon Feb 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue Feb 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
51
CPC classes
A61K, A61K48/00